Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Mini Reviews in Medicinal Chemistry|May 22, 2009
Cannabinoid system in neurodegeneration: new perspectives in Alzheimer's diseaseN E Campillo, J A PáezJournal of Medicinal Chemistry|August 28, 1999
Novel arylpyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxides as platelet aggregation inhibitors. 2. Optimization by quantitative structure-activity relationshipsN Campillo, P Goya, J A PáezEuropean Journal of Medicinal Chemistry|December 22, 2009
Neural computational prediction of oral drug absorption based on CODES 2D descriptorsA Guerra, N E Campillo, J A PáezCurrent Medicinal Chemistry|December 18, 2009
Chagas disease: progress and new perspectivesF Sánchez-Sancho, N E Campillo, J A PáezJournal of Medicinal Chemistry|November 7, 2000
Novel bronchodilators: synthesis, transamination reactions, and pharmacology of a series of pyrazino[2,3-c][1,2,6]thiadiazine 2, 2-dioxidesN Campillo, C García, P Goya, et al.Farmaco (Societa Chimica Italiana : 1989)|May 1, 1997
Heterocyclic structures useful in medicinal chemistry: the case of pyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxideP Goya, N Campillo, C García-Gómez, et al.Journal of Medicinal Chemistry|May 29, 1999
Novel arylpyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxides as inhibitors of platelet aggregation. 1. Synthesis and pharmacological evaluationN Campillo, C García, P Goya, et al.Il Farmaco; Edizione Scientifica|November 1, 1986
3,5-Diamino-1,2,6-thiadiazine 1,1-dioxide derivatives: synthesis and antiparasitic activityV J Arán, A G Bielsa, P Goya, et al.Toxicology in Vitro : an International Journal Published in Association with BIBRA|August 28, 2012
The value of selected in vitro and in silico methods to predict acute oral toxicity in a regulatory context: results from the European Project ACuteToxP Prieto, A Kinsner-Ovaskainen, S Stanzel, et al.Pageof 1